Multiple Myeloma Therapeutics Market Size, Share & Trends Analysis Report By Drug Class (Alkylating Agents, Immunomodulators, Anti-CD38 Monoclonal Antibody, Proteasome Inhibitor, Others), By Distribution Channel (Retail Pharmacies & Drug Stores, Hospital Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: September 08, 2026 | Author: Debashree Bora | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
  7. North America Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
    4. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    5. Canada
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
  8. Europe Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
    4. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    5. Germany
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    6. France
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    7. Spain
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    8. Italy
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    9. Russia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    10. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    11. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    12. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
  9. APAC Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
    4. China
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    5. Korea
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    6. Japan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    7. India
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    8. Australia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    9. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    10. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    11. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
    4. UAE
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    5. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    6. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    7. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    8. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    9. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    10. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
  11. LATAM Multiple Myeloma Therapeutics Market Size Analysis
    1. Introduction
    2. Multiple Myeloma Therapeutics Market Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
      1. Alkylating Agents
      2. Immunomodulators
      3. Anti-CD38 Monoclonal Antibody
      4. Proteasome Inhibitor
      5. Others
    3. Multiple Myeloma Therapeutics Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Retail Pharmacies & Drug Stores
      2. Hospital Pharmacies
      3. Online Pharmacies
    4. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    5. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    6. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    7. Chile
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    8. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
    9. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug Class 2022-2034 (USD MILLION/ Units)
        1. Alkylating Agents
        2. Immunomodulators
        3. Anti-CD38 Monoclonal Antibody
        4. Proteasome Inhibitor
        5. Others
      3. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Retail Pharmacies & Drug Stores
        2. Hospital Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. Multiple Myeloma Therapeutics Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Rhizen Pharmaceuticals S.A.
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Johnson and Johnson
    3. Terpenoid Therapeutics Inc.
    4. Ablynx NV
    5. Acceleron Pharma Inc.
    6. IGF Oncology LLC.
    7. ImmunGene Inc.
    8. Millennium Pharmaceuticals Inc.
    9. AB Science SA
    10. AbbVie Inc.
    11. Mirna Therapeutics
    12. RedHill Biopharma Ltd.
    13. Teva Pharmaceutical Industries Ltd.
    14. TG Therapeutics Inc.
    15. MimiVax LLC
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global Multiple Myeloma Therapeutics Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 3: Global Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 4: North America Multiple Myeloma Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 5: North America Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 6: North America Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 7: U.S. Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 8: U.S. Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: Canada Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 10: Canada Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 11: Europe Multiple Myeloma Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 12: Europe Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 13: Europe Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 14: U.K. Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 15: U.K. Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 16: Germany Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 17: Germany Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 18: France Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 19: France Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 20: Spain Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 21: Spain Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Italy Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 23: Italy Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 24: Russia Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 25: Russia Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 26: Nordic Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 27: Nordic Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Benelux Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 29: Benelux Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 30: Rest of Europe Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 31: Rest of Europe Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 32: APAC Multiple Myeloma Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 33: APAC Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 34: APAC Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 35: China Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 36: China Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Korea Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 38: Korea Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 39: Japan Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 40: Japan Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 41: India Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 42: India Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Australia Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 44: Australia Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 45: Taiwan Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 46: Taiwan Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 47: South East Asia Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 48: South East Asia Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 49: Rest of Asia-Pacific Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 50: Rest of Asia-Pacific Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 51: Middle East and Africa Multiple Myeloma Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 52: Middle East and Africa Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 53: Middle East and Africa Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 54: UAE Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 55: UAE Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Turkey Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 57: Turkey Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 58: Saudi Arabia Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 59: Saudi Arabia Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 60: South Africa Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 61: South Africa Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Egypt Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 63: Egypt Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 64: Nigeria Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 65: Nigeria Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 66: Rest of MEA Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 67: Rest of MEA Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: LATAM Multiple Myeloma Therapeutics Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 69: LATAM Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 70: LATAM Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: Brazil Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 72: Brazil Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 73: Mexico Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 74: Mexico Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 75: Argentina Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 76: Argentina Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 77: Chile Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 78: Chile Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 79: Colombia Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 80: Colombia Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: Rest of LATAM Multiple Myeloma Therapeutics Market Size and Forecast By Drug Class - 2022-2034 (USD Billion)

Table 82: Rest of LATAM Multiple Myeloma Therapeutics Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: